表紙:世界のエレクトロポレーション装置市場:2021~2028年
市場調査レポート
商品コード
1022288

世界のエレクトロポレーション装置市場:2021~2028年

Global Electroporation Instruments Market - 2021-2028

出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.26円
世界のエレクトロポレーション装置市場:2021~2028年
出版日: 2021年10月06日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界のエレクトロポレーション装置の市場規模は、今後拡大すると予測されています。

エレクトロポレーション装置は、電気伝導度に基づく分子生物学的技術を用いて、細胞膜に透過性を発生させ、目的の分子を受動的に通過させます。エレクトロポレーション装置は、バクテリアや哺乳類の細胞など、さまざまな種類の細胞に外来タンパク質を導入するのに有効です。

当レポートでは、世界のエレクトロポレーション装置市場について調査し、市場の概要とともに、製品別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 世界のエレクトロポレーション装置市場の調査手法と範囲

  • 調査手法
  • 調査の目的と調査範囲

第2章 世界のエレクトロポレーション装置市場-市場の定義と概要

第3章 世界のエレクトロポレーション装置市場-エグゼクティブサマリー

  • 製品別の市場内訳
  • 用途別の市場内訳
  • 地域別の市場内訳

第4章 世界のエレクトロポレーション装置市場-市場力学

  • 市場に影響を与える要因
    • 促進要因
    • 抑制要因
    • 市場機会
    • 影響分析

第5章 世界のエレクトロポレーション装置市場-業界分析

  • ポーターのファイブフォース分析
  • PEST分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 償還分析
  • アンメットニーズ

第6章 世界のエレクトロポレーション装置市場-COVID-19分析

  • 市場でのCovid-19の分析
    • COVID-19前の市場シナリオ
    • COVID-19現在の市場シナリオ
    • COVID-19後または将来のシナリオ
  • Covid-19における価格のダイナミクス
  • 需要と供給のスペクトル
  • パンデミック時の市場に関連する政府のイニシアチブ
  • メーカーの戦略的イニシアチブ
  • 結論

第7章 世界のエレクトロポレーション装置市場-製品別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、製品別
    • 市場魅力指数
  • トータルエレクトロポレーションシステム
    • イントロダクション
    • 市場規模分析、百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年
  • 真核生物エレクトロポレーションシステム
  • 微生物エレクトロポレーションシステム

第8章 世界のエレクトロポレーション装置市場-用途別

  • イントロダクション
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場魅力指数
  • タンパク質産生
    • イントロダクション
    • 市場規模分析、百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年
  • 生物医学調査
    • トランスジェニックモデル
    • 癌研究
    • 遺伝子およびタンパク質発現研究
    • 創薬および開発のための細胞ベースのマイクロアレイ
  • 治療デリバリー
    • 生物療法
    • 電気化学療法と電気免疫療法

第9章 世界のエレクトロポレーション装置市場-地域別

  • イントロダクション
    • 市場規模分析、百万米ドル、2018~2028年、および前年比成長分析(%)、2020~2028年、地域別
    • 地域別の市場魅力指数
  • 北米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、製品別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • 欧州
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、製品別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • 南米
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、製品別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • アジア太平洋
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、製品別
    • 市場規模分析、および前年比成長分析(%)、用途別
    • 市場規模分析、および前年比成長分析(%)、国別
  • 中東とアフリカ
    • イントロダクション
    • 主要な地域固有のダイナミクス
    • 市場規模分析、および前年比成長分析(%)、製品別
    • 市場規模分析、および前年比成長分析(%)、用途別

第10章 世界のエレクトロポレーション装置市場-競合情勢

  • 主な発展と戦略
  • 企業シェア分析
  • 製品のベンチマーク
  • 注目すべき主要企業
  • 破壊的技術を持つ企業
  • スタートアップ企業

第11章 世界のエレクトロポレーション装置市場-企業プロファイル概要

  • Bio-Rad Laboratories
    • 企業概要
    • タイプポートフォリオと概要
    • 主なハイライト
    • 財務概要
  • BEX Co. Ltd
  • Celetrix LLC
  • Merck KGaA
  • Eppendorf AG
  • Harvard Bioscience Inc.(BTX)
  • Thermo Fisher Scientific, Inc
  • MaxCyte Inc
  • Lonza Group
  • Mirus Bio LLC
  • Guangzhou Tingmay Beauty Equipment Co., Ltd
  • ALLFOND INDUSTRIAL LIMITED
  • Shanghai Apolo Medical Technology Co., Ltd

非網羅的リスト

第12章 世界のエレクトロポレーション装置市場-DataM

  • 付録
  • 当社・サービスについて
  • お問い合わせ
目次
Product Code: DMMD3818

Market Overview

The global electroporation instruments market size was valued US$ XX billion in 2019 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Electroporation instruments use a molecular biology technology based on electrical conductivity to generate permeability in the cell membrane through which molecule of interest can pass through it passively. Electroporation instruments are beneficial in introducing foreign proteins to different cell types, such as bacterial or mammalian cells.

Market Dynamics

The electroporation instruments market growth is driven by the Increasing research and development funding by public and private bodies. In addition, with the increase in the technological advancement in the field of nanotechnology, biotechnology, and pharmacology, increases its penetration rates, a collaboration between major market players and academic institutions, funding for research in electrophoresis technique, increasing focus on next-generation sequencing techniques, are some of the factors driving the growth of electroporation instrument market.

Development of vaccine delivery system using electroporation technology, is expected to drive the growth in the forecast period

The electroporation technique is widely preferred to enhance nucleic acid uptake with the DNA to generate an immune response against an antigen when the vaccine is delivered through the skin. The rise in the prevalence of infectious diseases and other skin disorders is likely to drive the demand for electroporation instruments. The potential of the electrophoresis method in locating the local antigen expression in the epidermis offers a significant advantage to patients. Electroporation technique creates an inflammatory environment, and hence, its association with DNA vaccination would result in strong expression of vaccine antigen, thus driving the global electroporation instruments market.

Progress in gene editing techniques, is expected to drive the growth in the forecast period

The advancements in gene-editing technologies, including regularly- interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins or transcription activator-like effector nucleases (TALENs), have enabled the researchers to curate targeted sequence-specific changes across the DNA- a factor that is expected to rise the adoption of electroporation instruments. As the advancements in gene-editing techniques occur at a steady pace, the prospects of this market continue to look at a bright future. Moreover, as applications of gene editing techniques continue to increase research and development, the adoption of electroporation instruments is likely to witness considerable growth. In addition, significant advancements in the electroporation instruments and electrodes coupled with the increasing compatibility with cutting-edge gene-editing technology are likely to play a key role in the overall development of the global electroporation instruments market.

Non-specific transport and other complications is likely to hamper the market growth

The electroporation methods have some disadvantages compared to other delivery systems. In some cases, non-specific transport of the material can result in an ion imbalance, leading to improper cell function and death. Irreversible electroporation could lead to cell homeostasis loss, widely considered an unconventional mode for cell death. The electroporation method causes complications and skin edema, as compared to other physical methods.

COVID-19 Impact Analysis

The COVID-19 impact on the global electroporation instruments market is expected to remain moderate in 2020, as the research and development activities are likely to remain unaffected. Moreover, the increasing adoption of gene-editing technology across the healthcare sector globally is likely to continue in 2020, due to which the electroporation instruments market is projected to witness the steady growth. As the precision medicines are playing an imperative role in assisting researchers and scientists to evaluate the new coronavirus, the demand for electroporation instruments is likely to grow. In addition, CRISPR-based diagnostics are increasingly being used to accurately diagnose a range of medical diseases, including the new COVID-19 infection- another factor that is expected to propel the market growth for electroporation instruments COVID-19 era.

Segment Analysis

The total electroporation system segment is expected to hold largest share in this market segment

An increase in the burden of diseases across the globe has prompted various healthcare organizations to focus on drug discovery and drug development. These studies require experimental drugs on human and other eukaryotic cells to study their mechanism of action and their safety profile. The rise in demand for multifaceted devices that can be used for all types of cell studies leading to overall cost-effectiveness, is anticipated to drive the total electroporation system during the forecast period.

The protein production segment is expected to hold largest share in this market segment

Protein production through the expression of mammalian cells is a major aspect of the biotechnology industry. Proteins such as erythropoietin and human growth hormones are efficiently utilized to treat cancers, infectious diseases, and autoimmune diseases. Moreover, most autoimmune diseases and cancer are treated by biotherapeutics, where protein is the primary ingredient for the production of biotherapeutics. To achieve this, electroporation is considered the highly preferred process in the delivery of protein to study the expression and development of treatment in the genomic engineering process.

Geographical Analysis

North America region holds the largest market share of global electroporation instruments market

The North American region dominated the global electroporation instruments market, followed by Europe. The rise in prevalence of cancer and autoimmune diseases in North America fueled the transfection technology market. Moreover, biotherapeutic drugs are highly preferred for the treatment of cancer and autoimmune diseases, and an increase in usage of these drugs is estimated to fuel the demand for transfection, as transfection is extensively employed to produce biotherapeutic drugs.

Competitive Landscape

The global electroporation instruments market is highly competitive with presence of global companies. Some of the key players which are contributing to the growth of the market include BEX Co. Ltd., Celetrix LLC, Merck KGaA, Eppendorf AG, Harvard Bioscience Inc. (BTX), Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, MaxCyte Inc., Lonza Group, and Mirus Bio LLC, Guangzhou Tingmay Beauty Equipment Co., Ltd, ALLFOND INDUSTRIAL LIMITED, Shanghai Apolo Medical Technology Co., Ltd. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally. For instance, In January 2018, Harvard Biosciences Inc. acquired Data Sciences International, Inc. worth US$ 71.1 Mn, which is a leading global player offering preclinical products, solutions, systems, and services to pharmaceutical, biotechnology, CROs, research laboratories, and government research institutes.

Electroporation Instruments Market Key Companies to Watch

Bio-Rad Laboratories

  • Overview: Bio-Rad, founded in 1952, is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With employees, more than 7,800, headquarters Hercules, California, USA. Bio-Rad is among the top five life science companies globally, providing instruments, software, consumables, reagents, and content for cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education. It is the world leader in clinical quality control products, services, and information systems, ensuring the accuracy and validity of clinical test results.
  • Product Portfolio: The Company's portfolio comprised of include life science research and clinical diagnostics.

Product - The Gene Pulser Xcell System is a flexible, modular electroporation system for transfecting every cell type from primary, suspension, and difficult-to-transfect cells, including T cells, to bacteria and fungi.

Why Purchase the Report?

  • Visualize the composition of the electroporation instruments market segmentation by product, application and region highlighting the key commercial assets and players.
  • Identify commercial opportunities in electroporation instruments market by analysing trends and co-development deals.
  • Excel data sheet with thousands of data points of electroporation instruments market - level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global electroporation instruments market report would provide an access to an approx. 53 market data table, 42 figures and 180 pages.

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Electroporation Instruments Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Electroporation Instruments Market - Market Definition and Overview

3. Global Electroporation Instruments Market - Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Global Electroporation Instruments Market - Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Development of vaccine delivery system using electroporation technology
      • 4.1.1.2. Progress in gene editing techniques
    • 4.1.2. Restraints:
      • 4.1.2.1. Non-specific transport and other complications
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Electroporation Instruments Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. PEST Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis
  • 5.6. Reimbursement Analysis
  • 5.7. Unmet Needs

6. Global Electroporation Instruments Market - COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Electroporation Instruments Market - By Product

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2. Market Attractiveness Index, By Product
  • 7.2. Total Electroporation System*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 7.3. Eukaryotic Electroporation System
  • 7.4. Microbial Electroporation System

8. Global Electroporation Instruments Market - By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Protein Production*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
  • 8.3. Bio-Medical Research
    • 8.3.1. Transgenic models
    • 8.3.2. Cancer Research
    • 8.3.3. Gene and Protein Expression Studies
    • 8.3.4. Cell-based Microarrays for Drug Discovery and Development
  • 8.4. Therapeutic Delivery
    • 8.4.1. Biotherapeutics
    • 8.4.2. Electro-chemotherapy and Electro-immunotherapy

9. Global Electroporation Instruments Market - By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. U.K.
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

10. Global Electroporation Instruments Market - Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Benchmarking
  • 10.4. Key Companies to Watch
  • 10.5. Company with disruptive technology
  • 10.6. Start Up Companies

11. Global Electroporation Instruments Market- Company Profiles

  • 11.1. Bio-Rad Laboratories*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. BEX Co. Ltd
  • 11.3. Celetrix LLC
  • 11.4. Merck KGaA
  • 11.5. Eppendorf AG
  • 11.6. Harvard Bioscience Inc. (BTX)
  • 11.7. Thermo Fisher Scientific, Inc
  • 11.8. MaxCyte Inc
  • 11.9. Lonza Group
  • 11.10. Mirus Bio LLC
  • 11.11. Guangzhou Tingmay Beauty Equipment Co., Ltd
  • 11.12. ALLFOND INDUSTRIAL LIMITED
  • 11.13. Shanghai Apolo Medical Technology Co., Ltd LIST NOT EXHAUSTIVE

12. Global Electroporation Instruments Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us